aglossia


Also found in: Medical.
Related to aglossia: ankyloglossia, macroglossia

aglossia

(əˈɡlɒsɪə)
n
(Pathology) pathol congenital absence of the tongue
[C19: from a-1 + glossa + -ia]
aˈglossal adj
aˈglossate adj
References in periodicals archive ?
glossitis, macroglossia, aglossia) and its associated anatomical structures (e.g.
Aglossia congenital: Report of a case of the condition combined with other congenital malformations.
Complete and isolated congenital aglossia: Case report and treatment of sequelae using rapid prototyping models.
Aglossia is a rare malformation resulting in the partial development or complete absence of the tongue.
Most cases of aglossia in literature have been described in correlation with other congenital or developmental defects.
Syndromes associated with Aglossia include Moebius, Hanhart, Pierre Robin, Charlie M, Pfaundler-Hurler, Orofacial-digital, Amniotic band and Glossopalantine-Ankylosis Syndrome.Mental stature is usually normal in such cases, but a case in conjunction with mental retardation has also been reported.7 Deafness has also been highlighted in some cases.8,9 Situs Inversus and more recently Hypothyroidism has also been observed with this malformation.10,11
Cranio-facial abnormalities reported in combination with this defect include cleft lip and palate, defects of the eye-lid, asymmetry of the face and cranial-nerve palsies.12 Aglossia appears to be congenital and sporadic in nature but it may be acquired due to surgery needed in case of malignancy.
The aglossia was probably compensated by the smooth floor of the mouth and the slight elevation of the floor during swallowing and speech.
The patient was not willing for any treatment for aglossia so only denture treatment was advised and replaced.
Introduction and objective: the aglossia adactylia syndrome is an infrequently occurring congenital polymalformative syndrome, having unclear aetiology and inheritance pattern.
Presentation of the case: a newborn having phenotypical aglossia adactylia syndrome characteristics, the son of a 17-year-old mother having antecedents of having used a 400 microgram oral dose and a 200 microgram vaginal dose of misoprostol at 10 weeks' gestation with the aim of interrupting her pregnancy.
Discussion: misoprostol is a synthetic prostaglandin E1 analogue; it has been associated with increased risk of Moebius sequence occurring, arthrogryposis, aglossia adactylia syndrome and terminal and cross-sectional extremity defects in mothers who have used this drug during their first gestation trimester.